Kelly Phillips

Underutilisation of breast cancer prevention medication in Australia.

Courtney Macdonald, James A Chamberlain, Danielle Mazza, Roger L Milne, undefined kConFab investigators, Kelly-Anne Phillips

Journal article  |  2021  |  Breast

Increased implementation of proven prevention strategies is required to combat rising breast cancer incidence. We assessed use of ..

The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations

Tamara Hettipathirana, Courtney Macdonald, Jing Xie, Kate Moodie, Chris Michael, Kelly-Anne Phillips

Journal article  |  2021  |  MEDICAL JOURNAL OF AUSTRALIA

OBJECTIVE: To assess the sensitivity and specificity of clinical breast examination for detecting breast cancer in asymptomatic wo..

Bilateral salpingo-oophorectomy and breast cancer risk for BRCA1 and BRCA2 mutation carriers: Assessing the evidence.

Ciara Conduit, Roger L Milne, Michael L Friedlander, Kelly-Anne Phillips

Journal article  |  2021  |  Cancer Prev Res (Phila)

Without preventive interventions, women with germline pathogenic variants in BRCA1 or BRCA2 have high lifetime risks for breast ca..

Mendelian randomisation study of smoking exposure in relation to breast cancer risk

Hanla A Park, Sonja Neumeyer, Kyriaki Michailidou, Manjeet K Bolla, Qin Wang, Joe Dennis, Thomas U Ahearn, Irene L Andrulis, Hoda Anton-Culver, Natalia N Antonenkova, Volker Arndt, Kristan J Aronson, Annelie Augustinsson, Adinda Baten, Laura E Beane Freeman, Heiko Becher, Matthias W Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, et al.

Journal article  |  2021  |  BRITISH JOURNAL OF CANCER

BACKGROUND: Despite a modest association between tobacco smoking and breast cancer risk reported by recent epidemiological studies..

Women and babies are dying from inertia: a collaborative framework for obstetrical drug development is urgently needed

Lieske H Schrijver, Antonis C Antoniou, Hakan Olsson, Thea M Mooij, Marie-Jose Roos-Blom, Leyla Azarang, Julian Adlard, Munaza Ahmed, Daniel Barrowdale, Rosemarie Davidson, Alan Donaldson, Ros Eeles, D Gareth Evans, Debra Frost, Alex Henderson, Louise Izatt, Kai-Ren Ong, Valerie Bonadona, Isabelle Coupier, Laurence Faivre, et al.

Journal article  |  2021  |  AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

BACKGROUND: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown to decrease with longer duration of oral contr..

Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution Needed

Ciara Conduit, Roger L Milne, Kelly-Anne Phillips

Journal article  |  2021  |  JAMA ONCOLOGY

Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.

Robert J MacInnis, Julia A Knight, Wendy K Chung, Roger L Milne, Alice S Whittemore, Richard Buchsbaum, Yuyan Liao, Nur Zeinomar, Gillian S Dite, Melissa C Southey, David Goldgar, Graham G Giles, Allison W Kurian, undefined kConFab Investigators, Irene L Andrulis, Esther M John, Mary B Daly, Saundra S Buys, Kelly-Anne Phillips, John L Hopper, et al.

Journal article  |  2021  |  J Natl Cancer Inst

BACKGROUND: Clinical guidelines often use predicted lifetime risk from birth to define criteria for making decisions regarding bre..

Assessment of Ovarian Function in Phase 3 (Neo)adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.

Wanyuan Cui, Prudence A Francis, Sherene Loi, Martha Hickey, Catharyn Stern, Lumine Na, Ann H Partridge, Sibylle Loibl, Richard A Anderson, Karla J Hutt, Louise A Keogh, Kelly-Anne Phillips

Journal article  |  2021  |  J Natl Cancer Inst

BACKGROUND: Loss of ovarian function is a recognized adverse effect of chemotherapy for breast cancer, and of great importance to ..

Survival from breast cancer in women with a BRCA2 mutation by treatment

D Gareth Evans, Kelly-Anne Phillips, Roger L Milne, Robert Fruscio, Cezary Cybulski, Jacek Gronwald, Jan Lubinski, Tomasz Huzarski, Zerin Hyder, Claire Forde, Kelly Metcalfe, Leigha Senter, Jeffrey Weitzel, Nadine Tung, Dana Zakalik, Maria Ekholm, Ping Sun, Steven A Narod

Journal article  |  2021  |  BRITISH JOURNAL OF CANCER

BACKGROUND: The impact of various breast-cancer treatments on patients with a BRCA2 mutation has not been studied. We sought to es..

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A O'Mara, Joe Dennis, Jonathan P Tyrer, Daniel R Barnes, Lesley McGuffog, Goska Leslie, Manjeet K Bolla, Muriel A Adank, Simona Agata, Thomas Ahearn, Kristiina Aittomaeki, Irene L Andrulis, Hoda Anton-Culver, Volker Arndt, Norbert Arnold, Kristan J Aronson, Banu K Arun, et al.

Journal article  |  2021  |  NATURE COMMUNICATIONS

Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants hav..